Benjamin Mead is a data scientist specializing in drug discovery with over five years of experience in leading teams to harness molecular, biological, and commercial data streams using applied ML/AI in therapeutic discovery. They held positions at notable institutions, including a research scientist role at the Broad Institute, and served as an associate director at Formation Bio. Benjamin completed their PhD in Medical Engineering and Medical Physics at MIT and contributed to significant research publications and symposium presentations throughout their educational and professional journey. Their passion lies in combining multidisciplinary science with strategic leadership to accelerate the development of impactful treatments for unmet medical needs.